Provides early detection of liver disease conditions in type-2 diabetic patients.
Why LIVERFASt™ ?
LIVERFASt™ provides the right diagnosis of liver disease conditions in type 2 diabetes patients
LIVERFASt™ Fibrosis Score Similar Performance for Cirrhosis: Type 2 Diabetics versus Non-Diabetics
Screening for NAFLD in patients with Metabolic Syndrome (MetS) and Type 2 Diabetes
Type 2 Diabetes & NAFLD Diagnosis: LIVERFASt™ Highly Correlates with Liver Biopsy Staging
Chalassani N., et al. Hepatology, 67: 328-357 | Aravind A., et al. Journal of Intelligent Learning Systems and Applications. 2020;12:31-49.| De Ledinghen V., et al. Hepatology 2020.72;1(Suppl):906A | Raskin M., et al. Hepatology 2020.72;1(Suppl):273A | Cohn B., et al. Hepatology 2020.72;1(Suppl):943A
How LIVERFASt™ Works?
LIVERFASt™ Test, provides earlier detection of liver disease condition in type 2 diabetes patients.
What LIVERFASt™ does?
LIVERFASt™ test, delivering/providing the right diagnosis of liver disease conditions in type 2 diabetes patients.
Why LIVERFASt™ is your best liver diagnostic tool for diabetic patients?
- Identifying presence of fatty liver in Diabetic patients.
- Better applicability and reliability compared to other routine liver test such as LFT, ultrasound or TE.
- Determines the presence of liver fibrosis, steatosis and inflammation.
